Bulletin
Investor Alert
×

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205657894/composite

$

7.90

Change

-0.02 -0.25%

Volume

Volume 129,436

Sep 17, 2019, 6:23 p.m.

Real time quotes

/zigman2/quotes/205657894/composite

Today's close

$ 8.04

$ 7.92

Change

-0.12 -1.49%

Day low

Day high

$7.72

$8.10

Open
Open: 8.05

52 week low

52 week high

$6.07

$25.13

Open

Market cap

$8.79B

Average volume

22.14M

P/E ratio

N/A

Rev. per Employee

$441,818

EPS

-3.83

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/teva

MarketWatch News on TEVA

  1. Opioid Stocks Fall as Purdue Announces Settlement, Bankruptcy

    9:33 a.m. Sept. 16, 2019

    - Josh Nathan-Kazis

  2. Purdue Is Inching Closer to Bankruptcy. Why Opioid Stocks Don’t Care.

    12:28 p.m. Sept. 12, 2019

    - Josh Nathan-Kazis

  3. Allergan Settles to Get Out of First Big Opioid Trial

    10:03 a.m. Aug. 30, 2019

    - Josh Nathan-Kazis

  4. Purdue Offers Deal on Opioids. What It Means For Other Drugmakers

    9:48 a.m. Aug. 28, 2019

    - Josh Nathan-Kazis

  5. Johnson & Johnson Loses Oklahoma Opioid Case

    5:50 p.m. Aug. 26, 2019

    - Josh Nathan-Kazis

  6. A Big Opioid Decision Is Coming

    12:56 p.m. Aug. 26, 2019

    - Josh Nathan-Kazis

  7. Shares of Teva up 3% on positive migraine trial

    8:42 a.m. Aug. 21, 2019

    - Sarah Toy

  8. Teva says FDA-approved generic EpiPen Jr is now available in the U.S. for $300 for 2-pack

    8:01 a.m. Aug. 20, 2019

    - Ciara Linnane

  9. Drug Stocks Sank After 2 in Congress Reopened Price-Fixing Inquiry

    9:48 a.m. Aug. 15, 2019

    - Josh Nathan-Kazis

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/teva

Other News on TEVA

  1. 9 Healthcare Stocks Moving In Tuesday's Pre-Market Session

    7:13 a.m. Today

    - benzinga.com

  2. Opioid Relief Rally Is Likely to Stall

    4:40 p.m. Sept. 16, 2019

    - Charley Grant

  3. Opioid Reckoning Hits Money Managers

    1:14 p.m. Sept. 13, 2019

    - Becky Yerak

  4. Amgen Is On The Right Track With Its Own Biosimilar To Rituxan

    9:45 a.m. Sept. 13, 2019

    - Seeking Alpha

  5. Vir Biotechnology Files U.S. IPO Plan

    2:35 p.m. Sept. 12, 2019

    - Seeking Alpha

  6. Buffett's Best & Worst Performing Stocks Thus Far in 2019

    10:59 a.m. Sept. 12, 2019

    - Zacks.com

  7. Short Sellers Can’t Make Up Their Minds on Big Pharma

    7:52 a.m. Sept. 12, 2019

    - 247WallSt.com

  8. Wall Street Breakfast: Another Wave Of Easing

    7:00 a.m. Sept. 12, 2019

    - Seeking Alpha

  9. Francis Chou's Chou Europe Fund Semi-Annual 2019 Commentary

    3:06 p.m. Sept. 11, 2019

    - GuruFocus.com

  10. Purdue Pharma nearing partial settlement of opioid cases

    12:57 p.m. Sept. 11, 2019

    - Seeking Alpha

  11. Teva Herceptin biosimilar OK'd in Canada

    10:29 a.m. Sept. 11, 2019

    - Seeking Alpha

  12. Teva Bonds: 8.8% Yield To Maturity Understates Upside

    8:34 p.m. Sept. 7, 2019

    - Seeking Alpha

  13. These Are Buffett's Worst-Performing Stocks of 2019

    6:18 p.m. Sept. 6, 2019

    - GuruFocus.com

  14. Loading more headlines...
/news/pressrelease/company/us/teva

Press Releases on TEVA

  1. Tendinitis Treatment Market : Industry Outlook, Size & Forecast 2018-2023

    7:40 a.m. Today

    - AmericaNewsHour

  2. Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference

    7:01 a.m. Today

    - GlobeNewswire

  3. Contraceptives Market Value, Production, Volume, Growth Predictions, and Forecast 2019 to 2028

    4:27 a.m. Today

    - marketresearch.biz

  4. Biosimilars Market Analysis, Bussiness Strategies, Segmentation and Forecasts 2019-2028

    3:37 a.m. Today

    - marketresearch.biz

  5. Duloxetine API market is anticipated to register a growth rate of CAGR 3.52%

    3:22 a.m. Today

    - AmericaNewsHour

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.